Aurobindo Pharma Limited (AUROPHARMA.NS)
INR 1266.0
(1.48%)
INR 1266.0
(1.48%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 109.54 Billion INR | -17.78% |
| 2022 | 133.23 Billion INR | 0.74% |
| 2021 | 132.26 Billion INR | -9.75% |
| 2020 | 146.55 Billion INR | 12.71% |
| 2019 | 130.02 Billion INR | 23.68% |
| 2018 | 105.13 Billion INR | 11.29% |
| 2017 | 94.46 Billion INR | 14.79% |
| 2016 | 82.29 Billion INR | 9.85% |
| 2015 | 74.91 Billion INR | 14.6% |
| 2014 | 65.37 Billion INR | 47.49% |
| 2013 | 44.32 Billion INR | 58.76% |
| 2012 | 27.91 Billion INR | 37.26% |
| 2011 | 20.33 Billion INR | -4.94% |
| 2010 | 21.39 Billion INR | 8.0% |
| 2009 | 19.81 Billion INR | 37.52% |
| 2008 | 14.4 Billion INR | 42.17% |
| 2007 | 10.13 Billion INR | 17.42% |
| 2006 | 8.62 Billion INR | 148.27% |
| 2005 | 3.47 Billion INR | -37.05% |
| 2004 | 5.52 Billion INR | -8.4% |
| 2003 | 6.02 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 30.18 Billion INR | -3.84% |
| 2023 Q2 | 39.13 Billion INR | 7.65% |
| 2023 Q3 | 41.2 Billion INR | 5.28% |
| 2023 Q4 | 31.38 Billion INR | -23.83% |
| 2023 FY | 109.54 Billion INR | -17.78% |
| 2023 Q1 | 36.35 Billion INR | 5.46% |
| 2022 FY | 133.23 Billion INR | 0.74% |
| 2022 Q2 | 31.05 Billion INR | -5.61% |
| 2022 Q1 | 32.9 Billion INR | 0.58% |
| 2022 Q3 | 34.8 Billion INR | 12.07% |
| 2022 Q4 | 34.47 Billion INR | -0.94% |
| 2021 Q2 | 33.84 Billion INR | 1.77% |
| 2021 Q3 | 32.45 Billion INR | -4.11% |
| 2021 Q4 | 32.71 Billion INR | 0.8% |
| 2021 Q1 | 33.25 Billion INR | -7.22% |
| 2021 FY | 132.26 Billion INR | -9.75% |
| 2020 Q2 | 38.62 Billion INR | 12.67% |
| 2020 Q3 | 37.8 Billion INR | -2.11% |
| 2020 FY | 146.55 Billion INR | 12.71% |
| 2020 Q4 | 35.84 Billion INR | -5.19% |
| 2020 Q1 | 34.27 Billion INR | -3.71% |
| 2019 Q1 | 31.46 Billion INR | 21.85% |
| 2019 FY | 130.02 Billion INR | 23.68% |
| 2019 Q4 | 35.6 Billion INR | 10.07% |
| 2019 Q3 | 32.34 Billion INR | 0.07% |
| 2019 Q2 | 32.32 Billion INR | 2.74% |
| 2018 Q1 | 23.43 Billion INR | -1.54% |
| 2018 FY | 105.13 Billion INR | 11.29% |
| 2018 Q4 | 25.81 Billion INR | -10.34% |
| 2018 Q3 | 28.79 Billion INR | 6.32% |
| 2018 Q2 | 27.08 Billion INR | 15.6% |
| 2017 Q1 | 21.8 Billion INR | 1.97% |
| 2017 FY | 94.46 Billion INR | 14.79% |
| 2017 Q4 | 23.79 Billion INR | -5.52% |
| 2017 Q3 | 25.18 Billion INR | -5.6% |
| 2017 Q2 | 26.67 Billion INR | 22.33% |
| 2016 Q3 | 21.96 Billion INR | 2.37% |
| 2016 FY | 82.29 Billion INR | 9.85% |
| 2016 Q2 | 21.45 Billion INR | 2.71% |
| 2016 Q1 | 20.88 Billion INR | -1.47% |
| 2016 Q4 | 21.38 Billion INR | -2.62% |
| 2015 Q2 | 18.64 Billion INR | 2.86% |
| 2015 Q4 | 21.2 Billion INR | 9.17% |
| 2015 Q3 | 19.41 Billion INR | 4.16% |
| 2015 Q1 | 18.12 Billion INR | 2.82% |
| 2015 FY | 74.91 Billion INR | 14.6% |
| 2014 Q1 | 15.3 Billion INR | 11.65% |
| 2014 FY | 65.37 Billion INR | 47.49% |
| 2014 Q4 | 17.62 Billion INR | 8.3% |
| 2014 Q3 | 16.27 Billion INR | 0.69% |
| 2014 Q2 | 16.16 Billion INR | 5.63% |
| 2013 FY | 44.32 Billion INR | 58.76% |
| 2013 Q4 | 13.7 Billion INR | 10.29% |
| 2013 Q1 | 8.24 Billion INR | 18.93% |
| 2013 Q2 | 9.94 Billion INR | 20.67% |
| 2013 Q3 | 12.42 Billion INR | 24.95% |
| 2012 FY | 27.91 Billion INR | 37.26% |
| 2012 Q4 | 6.93 Billion INR | -12.03% |
| 2012 Q3 | 7.87 Billion INR | 5.91% |
| 2012 Q1 | 5.67 Billion INR | 19.26% |
| 2012 Q2 | 7.43 Billion INR | 31.2% |
| 2011 Q3 | 5.79 Billion INR | 0.0% |
| 2011 Q4 | 4.75 Billion INR | -17.89% |
| 2011 FY | 20.33 Billion INR | -4.94% |
| 2010 FY | 21.39 Billion INR | 8.0% |
| 2009 FY | 19.81 Billion INR | 37.52% |
| 2008 FY | 14.4 Billion INR | 42.17% |
| 2007 FY | 10.13 Billion INR | 17.42% |
| 2006 FY | 8.62 Billion INR | 148.27% |
| 2005 FY | 3.47 Billion INR | -37.05% |
| 2004 FY | 5.52 Billion INR | -8.4% |
| 2003 FY | 6.02 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -5370.94% |
| Ind-Swift Limited | 2.17 Billion INR | -4942.216% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -7342.808% |
| Sakar Healthcare Limited | 699.58 Million INR | -15558.383% |
| Innova Captab Limited | 3.46 Billion INR | -3061.945% |
| Divi's Laboratories Limited | 32.44 Billion INR | -237.681% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -1660.389% |
| Morepen Laboratories Limited | 6.16 Billion INR | -1677.937% |
| Mankind Pharma Limited | 42.19 Billion INR | -159.601% |
| Sequent Scientific Limited | 2.97 Billion INR | -3577.53% |
| Wanbury Limited | 1.73 Billion INR | -6229.653% |
| Laurus Labs Limited | 15.44 Billion INR | -609.08% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -2171.141% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -781.073% |
| Alembic Limited | 1 Billion INR | -10853.198% |
| Hikal Limited | 5.95 Billion INR | -1738.599% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -309.04% |
| Neuland Laboratories Limited | 8.24 Billion INR | -1228.15% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -617.9% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | -57.979% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -2221.284% |
| Themis Medicare Limited | 2.42 Billion INR | -4426.586% |
| RPG Life Sciences Limited | 2.48 Billion INR | -4311.748% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 12.513% |
| Lupin Limited | 125.09 Billion INR | 12.432% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -5131.221% |
| Wockhardt Limited | 7.72 Billion INR | -1318.96% |
| Vaishali Pharma Limited | 90.32 Million INR | -121179.962% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -1778.53% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -16685.991% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -457.673% |
| FDC Limited | 6.58 Billion INR | -1563.228% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 33.045% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -17554.756% |
| Eris Lifesciences Limited | 10.42 Billion INR | -950.599% |
| Venus Remedies Limited | 2.18 Billion INR | -4918.989% |
| ZIM Laboratories Limited | 1.26 Billion INR | -8540.367% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -2864.298% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -20602.371% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -1089.852% |
| Shilpa Medicare Limited | 3.56 Billion INR | -2975.431% |
| Albert David Limited | 1.4 Billion INR | -7679.612% |
| Ajanta Pharma Limited | 21.06 Billion INR | -420.052% |
| Hester Biosciences Limited | 1.27 Billion INR | -8500.769% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -2556.716% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 6715.357% |
| Gufic Biosciences Limited | 4.07 Billion INR | -2589.025% |
| Windlas Biotech Limited | 1.33 Billion INR | -8082.23% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -1794.761% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -96816.455% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -15748.497% |
| Granules India Limited | 16.79 Billion INR | -552.074% |
| Aarti Drugs Limited | 8.31 Billion INR | -1217.232% |
| Bal Pharma Limited | 770.19 Million INR | -14122.853% |
| Alkem Laboratories Limited | 52.29 Billion INR | -109.465% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 57.621% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -5705.59% |
| Medicamen Biotech Limited | 495.49 Million INR | -22007.932% |
| Unichem Laboratories Limited | 4.86 Billion INR | -2151.701% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -24127.131% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -873106.058% |
| Valiant Laboratories Limited | 138.02 Million INR | -79262.815% |
| Orchid Pharma Limited | 2.32 Billion INR | -4621.095% |
| Medico Remedies Limited | 262.14 Million INR | -41687.605% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -2550.325% |
| Ipca Laboratories Limited | 48.58 Billion INR | -125.472% |
| Brooks Laboratories Limited | 65.62 Million INR | -166836.452% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -19478.751% |
| Piramal Enterprises Limited | 8.04 Billion INR | -1261.925% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | -134.281% |
| NATCO Pharma Limited | 25.73 Billion INR | -325.644% |
| Suven Life Sciences Limited | -200.79 Million INR | 54654.451% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 100832.618% |
| Strides Pharma Science Limited | 14.38 Billion INR | -661.349% |
| Indoco Remedies Limited | 8.04 Billion INR | -1261.976% |
| Alpa Laboratories Limited | 188.89 Million INR | -57891.847% |
| Lasa Supergenerics Limited | 121.02 Million INR | -90409.544% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -27911.563% |